标题
The role of GATA2 in lethal prostate cancer aggressiveness
作者
关键词
-
出版物
Nature Reviews Urology
Volume 14, Issue 1, Pages 38-48
出版商
Springer Nature
发表日期
2016-11-22
DOI
10.1038/nrurol.2016.225
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Drugging Undruggable Molecular Cancer Targets
- (2016) John S. Lazo et al. Annual Review of Pharmacology and Toxicology
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression
- (2016) J C Zhao et al. ONCOGENE
- The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study
- (2016) Hakim Mahammedi et al. ONCOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Targetable GATA2-IGF2 Axis Confers Aggressiveness in Lethal Prostate Cancer
- (2015) Samuel J. Vidal et al. CANCER CELL
- Notch signaling: An emerging therapeutic target for cancer treatment
- (2015) Xun Yuan et al. CANCER LETTERS
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis
- (2015) Alexey A. Dmitriev et al. DISEASE MARKERS
- Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
- (2015) Laurence Klotz et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- The oncogene ERG: a key factor in prostate cancer
- (2015) P Adamo et al. ONCOGENE
- A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination
- (2015) Channing J. Paller et al. PROSTATE
- Curcumin Targets in Inflammation and Cancer
- (2015) Atsuko Deguchi Endocrine Metabolic & Immune Disorders-Drug Targets
- GATA2 as a potential metastasis-driving gene in prostate cancer
- (2015) Yan Ting Chiang et al. Oncotarget
- Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols
- (2014) Subash C. Gupta et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- p38 links RAS to GATA2
- (2014) C. Baumgartner et al. EMBO REPORTS
- Molecular basis of crosstalk between oncogenic Ras and the master regulator of hematopoiesis GATA-2
- (2014) K. R. Katsumura et al. EMBO REPORTS
- Pioneer transcription factors in cell reprogramming
- (2014) Makiko Iwafuchi-Doi et al. GENES & DEVELOPMENT
- A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation
- (2014) Takashi Moriguchi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Epigenetic regulation of GATA2 and its impact on normal karyotype acute myeloid leukemia
- (2014) M Celton et al. LEUKEMIA
- NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer
- (2014) Angela N. Flores et al. Nature Reviews Urology
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer
- (2014) Dayong Wu et al. NUCLEIC ACIDS RESEARCH
- GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex
- (2014) Bin He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer—the UK NCRN Pomi-T study
- (2014) R Thomas et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The Notch Delta-4 ligand helps to maintain the quiescence and the short-term reconstitutive potential of haematopoietic progenitor cells through activation of a key gene network
- (2014) Cyril Catelain et al. Stem Cell Research
- Lysine-Specific Demethylase 1 Has Dual Functions as a Major Regulator of Androgen Receptor Transcriptional Activity
- (2014) Changmeng Cai et al. Cell Reports
- GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2
- (2013) Silvia Coma et al. ANGIOGENESIS
- RNAi screen identifies Jarid1b as a major regulator of mouse HSC activity
- (2013) S. Cellot et al. BLOOD
- GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity
- (2013) M. A. Spinner et al. BLOOD
- IGF2 and cancer
- (2013) Callum Livingstone ENDOCRINE-RELATED CANCER
- Hedgehog Signaling in Prostate Cancer and Its Therapeutic Implication
- (2013) Annelies Gonnissen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SON Protein Regulates GATA-2 through Transcriptional Control of the MicroRNA 23a∼27a∼24-2 Cluster
- (2013) Erin Eun-Young Ahn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Castration-Resistant Prostate Cancer: AUA Guideline
- (2013) Michael S. Cookson et al. JOURNAL OF UROLOGY
- Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia
- (2013) E H Estey LEUKEMIA
- Hypoxia, notch signalling and prostate cancer
- (2013) Laure Marignol et al. Nature Reviews Urology
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
- (2013) T Karantanos et al. ONCOGENE
- Notch inhibitors for cancer treatment
- (2013) Ingrid Espinoza et al. PHARMACOLOGY & THERAPEUTICS
- Homopiperazine Derivatives as a Novel Class of Proteasome Inhibitors with a Unique Mode of Proteasome Binding
- (2013) Jiro Kikuchi et al. PLoS One
- Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
- (2012) Josep Domingo-Domenech et al. CANCER CELL
- Targeting Pioneering Factor and Hormone Receptor Cooperative Pathways to Suppress Tumor Progression
- (2012) S. Shah et al. CANCER RESEARCH
- The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
- (2012) Madhu S. Kumar et al. CELL
- Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling
- (2012) Jordi Guiu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Discovery of small molecule cancer drugs: Successes, challenges and opportunities
- (2012) Swen Hoelder et al. Molecular Oncology
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Adaptation or selection—mechanisms of castration-resistant prostate cancer
- (2012) Yang Zong et al. Nature Reviews Urology
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies
- (2012) E. H. Bresnick et al. NUCLEIC ACIDS RESEARCH
- Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency
- (2011) R. E. Dickinson et al. BLOOD
- Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
- (2011) A. P. Hsu et al. BLOOD
- Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth
- (2011) David J. Mulholland et al. CANCER CELL
- The role of the GATA2 transcription factor in normal and malignant hematopoiesis
- (2011) Carmen Vicente et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth
- (2011) Zhong Chen et al. EMBO JOURNAL
- Pioneer transcription factors: establishing competence for gene expression
- (2011) K. S. Zaret et al. GENES & DEVELOPMENT
- ERG dependence distinguishes developmental control of hematopoietic stem cell maintenance from hematopoietic specification
- (2011) S. Taoudi et al. GENES & DEVELOPMENT
- Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)
- (2011) Pia Ostergaard et al. NATURE GENETICS
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNAs Associated with Metastatic Prostate Cancer
- (2011) Akira Watahiki et al. PLoS One
- Quantitative Models of the Mechanisms That Control Genome-Wide Patterns of Transcription Factor Binding during Early Drosophila Development
- (2011) Tommy Kaplan et al. PLoS Genetics
- Emberger syndrome-Primary lymphedema with myelodysplasia: Report of seven new cases
- (2010) Sahar Mansour et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- The Notch2–Jagged1 interaction mediates stem cell factor signaling in erythropoiesis
- (2010) A Zeuner et al. CELL DEATH AND DIFFERENTIATION
- Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation
- (2010) Qihuang Jin et al. EMBO JOURNAL
- GATA Switches as Developmental Drivers
- (2010) Emery H. Bresnick et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen
- (2010) Hisamitsu Ide et al. PROSTATE
- Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer
- (2010) Karen E. Knudsen et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
- Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor
- (2009) Mark J Mulvihill et al. Future Medicinal Chemistry
- Molecular mechanisms of castration-resistant prostate cancer progression
- (2009) Smitha S Dutt et al. Future Oncology
- A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes
- (2009) M Böhm et al. ONCOGENE
- A Boost of BMP4 Accelerates the Commitment of Human Embryonic Stem Cells to the Endothelial Lineage
- (2009) Orit Goldman et al. STEM CELLS
- Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
- (2009) William P Harris et al. Nature clinical practice. Urology
- Molecular and developmental biology of the hemangioblast
- (2008) Jing-Wei Xiong DEVELOPMENTAL DYNAMICS
- Impaired embryonic haematopoiesis yet normal arterial development in the absence of the Notch ligand Jagged1
- (2008) Àlex Robert-Moreno et al. EMBO JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now